Photophysical properties of Pt(II) and Pd(II) complexes for two-photon photodynamic therapy: A computational investigation
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nonlinear Optical Materials Studies · Quantum Dots Synthesis And Properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges
2. Features of third generation photosensitizers used in anticancer photodynamic therapy: review10.1016/j.pdpdt.2020.102091 ↗
3. Clinical development and potential of photothermal and photodynamic therapies for cancer. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
4. BODIPY-based photodynamic agents for exclusively generating superoxide radical over singlet oxygen10.1002/anie.202106748 ↗
5. An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers10.1038/s41467-022-29862-9 ↗
6. Water-soluble nanoparticles with twisted double[7]Carbohelicene for lysosome-targeted cancer photodynamic therapy
7. Theoretical exploration of the photophysical properties of two-component RuII-porphyrin dyes as promising assemblies for a combined antitumor effect10.1039/D0DT02197K ↗
8. Theoretical investigation on bisarylselanylbenzo-2,1,3-selenadiazoles as potential photosensitizers in photodynamic therapy10.1063/5.0038326 ↗
9. Iodine substituted phosphorus corrole complexes as possible photosensitizers in photodynamic therapy: insights from theory10.1002/jcc.26183 ↗
10. Activation by glutathione in hypoxic environment of an azo-based rhodamine activatable photosensitizer. A computational elucidation10.1002/chem.202104083 ↗
11. The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer10.1039/C9CS00129H ↗
12. Phototherapeutic anticancer strategies with first-row transition metal complexes: a critical review10.1039/D1CS00609F ↗
13. Coordination complexes as a new generation photosensitizer for photodynamic anticancer therapy10.3390/ijms22158052 ↗
14. Versatile strategy to generate a rhodamine triplet state as mitochondria-targeting visible-light photosensitizers for efficient photodynamic therapy10.1021/acsami.8b20224 ↗
15. Rationally designed long-wavelength absorbing Ru(II) polypyridyl complexes as photosensitizers for photodynamic therapy10.1021/jacs.9b13620 ↗
16. Visible-light-induced annihilation of tumor cells with platinum-porphyrin conjugates10.1002/anie.201400533 ↗
17. Two-photon small-molecule fluorescence-based agents for sensing, imaging, and therapy within biological systems10.1039/D0CS00861C ↗
18. Two-photon excitation nanoparticles for photodynamic therapyt10.1039/C6CS00442C ↗
19. A valproic acid-modified platinum diimine complex as potential photosensitizer for photodynamic therapy10.1016/j.jinorgbio.2021.111508 ↗
20. Photophysical exploration of dual-approach Pt-II-BODIPY conjugates: theoretical insights10.1021/acs.inorgchem.9b01002 ↗
21. A platinum(II) complex of heptamethine cyanine for photoenhanced cytotoxicity and cellular imaging in near-IR light10.1002/anie.201806911 ↗
22. Platinum-based two-photon photosensitizer responsive to NIR light in tumor hypoxia microenvironment10.1021/acs.jmedchem.2c00141 ↗
23. Palladium porphyrin complexes for photodynamic cancer therapy: effect of porphyrin units and metal10.1039/c9pp00363k ↗
24. Photodynamic effect of palladium porphyrin derived from cashew nut shell liquid against promastigote forms of Leishmania braziliensis10.1016/j.pdpdt.2020.102083 ↗
25. Investigation of powerful fungicidal activity of tetra-cationic platinum(II) and palladium(II) porphyrins by antimicrobial photodynamic therapy assays10.1016/j.pdpdt.2021.102550 ↗
26. Pawłowski, F.; Ortiz, J. Electron propagator calculations of vertical electron binding energies and dyson orbitals in Gaussian16.
27. Two-photon absorption in solution by means of time-dependent density-functional theory and the polarizable continuum model10.1063/1.1944727 ↗
28. Quantum mechanical continuum solvation models for ionic liquids10.1021/jp304365v ↗
29. Evaluation of spin-orbit couplings with linear-response time-dependent density functional methods10.1021/acs.jctc.6b00915 ↗
30. A multifunctional wavefunction analyzer10.1002/jcc.22885 ↗
31. Vmd: visual molecular dynamics10.1016/0263-7855(96)00018-5 ↗
32. The Dalton quantum chemistry program system10.1002/wcms.1172 ↗
33. Benchmarking two-photon absorption cross sections: performance of CC2 and CAM-B3LYP10.1039/C5CP03241E ↗
34. Multiphoton spectroscopy10.1146/annurev.pc.18.100167.001313 ↗
35. Theoretical exploration of type I/type II dual photoreactivity of promising Ru(II) dyads for PDT approach10.1021/acs.inorgchem.6b01782 ↗
36. A theoretical investigation into the luminescent properties of d8-transition-metal complexes with tetradentate schiff base ligands10.1002/chem.201304375 ↗
37. Theoretical investigation of the effect of alkylation and bromination on intersystem crossing in BODIPY-based photosensitizers10.1021/acs.jpcb.1c05236 ↗
38. Activation by glutathione in hypoxic environment of an azo-based rhodamine activatable photosensitizer. A computational elucidation10.1002/chem.202104083 ↗
39. Photophysical origin of the reduced photodynamic therapy activity of temocene compared to Foscan®: insights from theory10.1039/c3cp52698d ↗
40. Spin–orbit coupling and intersystem crossing in molecules10.1002/wcms.83 ↗
41. An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers10.1038/s41467-022-29862-9 ↗
42. Cationization-enhanced type I and type II ROS generation for photodynamic treatment of drug-resistant bacteria10.1021/acsnano.2c01206 ↗
43. Theoretical investigation on bisarylselanylbenzo-2,1,3-selenadiazoles as potential photosensitizers in photodynamic therapy10.1063/5.0038326 ↗
44. Recent development of the transition metal complexes showing strong absorption of visible light and long-lived triplet excited state: from molecular structure design to photophysical properties and applications10.1016/j.ccr.2020.213371 ↗
45. Theoretical exploration of the photophysical properties of two-component RuII–porphyrin dyes as promising assemblies for a combined antitumor effect10.1039/D0DT02197K ↗
46. Oncologic photodynamic therapy: basic principles, current clinical status and future directions10.3390/cancers9020019 ↗